Brief: Interpace Biosciences Announces Third Quarter 2022 Financial, Business Results

Interpace Biosciences

14/11/2022 22:24

Nov 14 (Reuters) - Interpace Biosciences Inc  IDXG.PK :
    * INTERPACE BIOSCIENCES ANNOUNCES THIRD QUARTER 2022
FINANCIAL AND
BUSINESS RESULTS SALE OF PHARMA SIGNIFICANTLY IMPROVES LIQUIDITY
RESULTING IN REMOVAL OF GOING CONCERN
    * INTERPACE BIOSCIENCES INC Q3 REVENUE ROSE 2 PERCENT TO
$8.2
MILLION

Source text for Eikon:  ID:nGNX7KWym7 
Further company coverage:  IDXG.PK 
 ((Reuters.Briefs@thomsonreuters.com;))